• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑质:肌肉松弛药物的作用部位。

Substantia nigra: a site of action of muscle relaxant drugs.

作者信息

Turski L, Klockgether T, Schwarz M, Turski W A, Sontag K H

机构信息

Max-Planck-Institute for Experimental Medicine, Göttingen, Federal Republic of Germany.

出版信息

Ann Neurol. 1990 Sep;28(3):341-8. doi: 10.1002/ana.410280307.

DOI:10.1002/ana.410280307
PMID:1978634
Abstract

Sites of action of centrally active muscle relaxant drugs are not well defined. Clinical experience with such drugs suggests that the spinal cord may be one of the important regions from which pathologically increased muscle tone may be relieved. Supraspinal centers that may also be involved in the expression of muscle relaxant action have not yet been defined. We report here that microinjections of therapeutically relevant muscle relaxants into the midbrain tegmentum of genetically spastic rats decrease muscle tone. The substantia nigra is the region from which midazolam, baclofen, and tizanidine (drugs used clinically in the treatment of spasticity), or gamma-vinyl-GABA, (-)-2-amino-7-phosphonoheptanoate, and [D-pro2-D-phe7-D-trp9]-substance P (experimental drugs active in animal models of spasticity), reduce muscle tone in genetically spastic rats and Hoffmann reflexes in normal rats. The effects of muscle relaxant drugs are topographically restricted to the substantia nigra pars reticulata and are receptor specific. These observations disclose a previously unknown function of the substantia nigra in mediating muscle relaxation.

摘要

中枢性肌肉松弛药物的作用部位尚未明确界定。此类药物的临床经验表明,脊髓可能是可缓解病理性肌张力增高的重要部位之一。可能也参与肌肉松弛作用表达的脊髓以上中枢尚未明确。我们在此报告,向遗传性痉挛大鼠的中脑被盖微量注射具有治疗相关性的肌肉松弛剂可降低肌张力。黑质是咪达唑仑、巴氯芬和替扎尼定(临床上用于治疗痉挛的药物)或γ-乙烯基-GABA、(-)-2-氨基-7-膦酰庚酸以及[D-脯氨酸2-D-苯丙氨酸7-D-色氨酸9]-P物质(在痉挛动物模型中具有活性的实验性药物)可降低遗传性痉挛大鼠肌张力并减弱正常大鼠霍夫曼反射的区域。肌肉松弛药物的作用在地形学上局限于黑质网状部,且具有受体特异性。这些观察结果揭示了黑质在介导肌肉松弛方面此前未知的功能。

相似文献

1
Substantia nigra: a site of action of muscle relaxant drugs.黑质:肌肉松弛药物的作用部位。
Ann Neurol. 1990 Sep;28(3):341-8. doi: 10.1002/ana.410280307.
2
Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.β-咔啉阿贝卡尼对小鼠脊髓反射及遗传性痉挛大鼠肌张力的影响:与地西泮的比较
J Pharmacol Exp Ther. 1993 Dec;267(3):1215-20.
3
Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine.黑质和脚内核:替扎尼定肌肉松弛作用的脊髓上部位。
Brain Res. 1986 Aug 6;379(2):367-71. doi: 10.1016/0006-8993(86)90792-4.
4
Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity.替扎尼定与痉挛患者脊髓控制机制的电生理分析
Neurology. 1994 Nov;44(11 Suppl 9):S21-7; discussion S27-8.
5
Antispasticity drugs: mechanisms of action.抗痉挛药物:作用机制
Ann Neurol. 1985 Feb;17(2):107-16. doi: 10.1002/ana.410170202.
6
GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.γ-氨基丁酸能机制对黑质网状部神经元活动状态的调节作用
Neuroscience. 2006 Jul 21;140(4):1289-99. doi: 10.1016/j.neuroscience.2006.03.064. Epub 2006 May 19.
7
Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity.巴氯芬对慢性痉挛性脊髓损伤大鼠运动神经元的脊髓反射和持续性内向电流的影响。
J Neurophysiol. 2004 Nov;92(5):2694-703. doi: 10.1152/jn.00164.2004.
8
[Medical treatment of spasticity].[痉挛的医学治疗]
Neurochirurgie. 2003 May;49(2-3 Pt 2):247-55.
9
Spasticity: a review.痉挛:综述
Neurology. 1994 Nov;44(11 Suppl 9):S12-20.
10
Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.托哌酮类药物通过阻断电压门控钠通道和钙通道来抑制脊髓反射。
J Pharmacol Exp Ther. 2005 Dec;315(3):1237-46. doi: 10.1124/jpet.105.089805. Epub 2005 Aug 26.

引用本文的文献

1
[Respiratory failure due to delta-9-tetrahydrocannabinol in a tetraplegic patient].[一名四肢瘫痪患者因 Δ-9-四氢大麻酚导致呼吸衰竭]
Schmerz. 2006 Nov;20(6):532-5. doi: 10.1007/s00482-006-0474-7.
2
Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.不同小鼠品系对GABA B受体激动剂巴氯芬的运动和体温降低作用的差异敏感性。
Psychopharmacology (Berl). 2005 May;179(3):688-99. doi: 10.1007/s00213-004-2086-1. Epub 2005 Jan 25.
3
Therapeutic potential of cannabinoids in CNS disease.
大麻素在中枢神经系统疾病中的治疗潜力。
CNS Drugs. 2003;17(3):179-202. doi: 10.2165/00023210-200317030-00004.
4
Alprazolam dependence prevented by substituting with the beta-carboline abecarnil.用β-咔啉阿贝卡尼替代可预防阿普唑仑依赖。
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2719-23. doi: 10.1073/pnas.94.6.2719.
5
Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.替扎尼定。关于其在治疗与脑和脊髓疾病相关的痉挛方面的药理学、临床疗效及耐受性的综述。
Drugs. 1997 Mar;53(3):435-52. doi: 10.2165/00003495-199753030-00007.